Novartis Institute for Tropical Diseases and Global Alliance for TB Drug Development announce five-year collaboration targeted to accelerate TB treatment R&D

in

  • The NITD and the TB Alliance's collaboration aims to move projects quickly from the research phase through the translational stage and into development


  • Both partners will leverage their broad networks of expertise and resources to rapidly bring effective, simpler treatments to patients